| Lactose (India) Ltd | 123 Cr. | 97.4 | 197/84.3 | 27.1 | 49.6 | 0.00 % | 12.9 % | 9.69 % | 10.0 |
| MPS Pharmaa Ltd | 3.21 Cr. | 1.68 | 4.29/1.68 | | 0.33 | 0.00 % | 9.79 % | 59.0 % | 10.0 |
| Gujarat Themis Biosyn Ltd | 3,370 Cr. | 310 | 479/192 | 69.8 | 24.3 | 0.22 % | 27.3 % | 21.7 % | 1.00 |
| Gujarat Terce Laboratories Ltd | 33.0 Cr. | 44.5 | 82.8/37.2 | | 10.6 | 0.00 % | 41.4 % | 14.6 % | 10.0 |
| Gujarat Inject (Kerala) Ltd | 69.7 Cr. | 47.6 | 47.6/17.0 | 166 | 6.93 | 0.00 % | 13.5 % | 11.0 % | 10.0 |
| Godavari Drugs Ltd | 67.1 Cr. | 89.0 | 115/69.7 | 18.1 | 60.3 | 0.00 % | 10.1 % | 10.6 % | 10.0 |
| Glenmark Life Sciences Ltd | 56,056 Cr. | 1,986 | 2,286/1,275 | 22.3 | 340 | 0.13 % | 19.4 % | 15.8 % | 1.00 |
| Gennex Laboratories Ltd | 295 Cr. | 12.2 | 17.2/10.8 | 17.7 | 8.79 | 0.00 % | 13.0 % | 10.2 % | 1.00 |
| Ganga Pharmaceuticals Ltd | 7.09 Cr. | 12.0 | 14.8/9.25 | 88.6 | 14.0 | 0.00 % | 3.18 % | 1.13 % | 10.0 |
| Fredun Pharmaceuticals Ltd | 825 Cr. | 1,538 | 1,999/635 | 28.6 | 334 | 0.05 % | 18.9 % | 15.8 % | 10.0 |
| Fervent Synergies Ltd | 93.0 Cr. | 18.6 | 29.8/17.0 | 25.4 | 10.8 | 0.00 % | 7.47 % | 7.47 % | 10.0 |
| Fermenta Biotech Ltd | 949 Cr. | 322 | 449/219 | 8.47 | 133 | 0.78 % | 23.0 % | 24.9 % | 5.00 |
| Fabino Enterprises Ltd | 2.94 Cr. | 14.0 | 39.0/13.0 | | 19.2 | 0.00 % | 7.16 % | 3.08 % | 10.0 |
| Evoq Remedies Ltd | 7.40 Cr. | 2.97 | 8.28/2.11 | 4.20 | 17.9 | 0.00 % | 0.35 % | 0.26 % | 10.0 |
| Everest Organics Ltd | 393 Cr. | 405 | 536/211 | 59.4 | 74.7 | 0.00 % | 1.76 % | 2.23 % | 10.0 |
| Entero Healthcare Solutions Ltd | 4,820 Cr. | 1,105 | 1,565/944 | 43.6 | 406 | 0.00 % | 8.71 % | 5.63 % | 10.0 |
| Murae Organisor Ltd | 40.9 Cr. | 0.20 | 1.12/0.20 | 2.69 | 1.02 | 0.00 % | 4.20 % | 5.69 % | 1.00 |
| Dipna Pharmachem Ltd | 37.8 Cr. | 14.4 | 26.3/11.2 | 18.4 | 24.5 | 0.00 % | 6.64 % | 2.55 % | 10.0 |
| Decipher Labs Ltd | 7.88 Cr. | 7.80 | 15.0/7.50 | | 19.0 | 0.00 % | 4.67 % | 1.16 % | 10.0 |
| Coral Laboratories Ltd | 155 Cr. | 435 | 851/415 | 8.79 | 596 | 0.35 % | 17.4 % | 13.1 % | 10.0 |
| Concord Drugs Ltd | 70.3 Cr. | 70.3 | 92.5/26.1 | 133 | 34.4 | 0.00 % | 4.73 % | 0.88 % | 10.0 |
| Concord Biotech Ltd | 12,270 Cr. | 1,175 | 2,452/1,156 | 38.2 | 174 | 0.91 % | 28.4 % | 21.4 % | 1.00 |
| Colinz Laboratories Ltd | 9.96 Cr. | 79.0 | 88.7/36.1 | 20.3 | 39.2 | 0.00 % | 6.72 % | 5.43 % | 10.0 |
| Cian Healthcare Ltd | 12.5 Cr. | 5.01 | 7.66/2.99 | | 13.0 | 0.00 % | 10.6 % | 30.3 % | 10.0 |
| Chemo Pharma Laboratories Ltd | 18.3 Cr. | 122 | 153/63.0 | | 9.60 | 0.00 % | 5.17 % | 3.47 % | 10.0 |
| Checkpoint Trends Ltd | 65.2 Cr. | 119 | 144/9.41 | 31.6 | 3.60 | 0.00 % | 16.5 % | 9.17 % | 10.0 |
| Chandra Bhagat Pharma Ltd | 31.8 Cr. | 42.1 | 73.0/33.0 | 51.2 | 40.3 | 0.00 % | 6.00 % | 2.41 % | 10.0 |
| Brawn Biotech Ltd | 6.35 Cr. | 21.2 | 24.4/15.5 | | 12.3 | 0.00 % | 42.5 % | 41.3 % | 10.0 |
| Blue Jet Healthcare Ltd | 7,240 Cr. | 418 | 1,028/411 | 20.6 | 72.4 | 0.29 % | 39.8 % | 30.2 % | 2.00 |
| Bharat Immunological & Biological Corporation Ltd | 77.5 Cr. | 18.0 | 29.6/16.6 | | 18.2 | 0.00 % | 9.27 % | 17.7 % | 10.0 |
| Beryl Drugs Ltd | 11.2 Cr. | 22.0 | 37.5/17.4 | 48.5 | 18.6 | 0.00 % | 10.2 % | 6.30 % | 10.0 |
| Mankind Pharma Ltd | 87,623 Cr. | 2,124 | 2,727/2,059 | 52.6 | 376 | 0.05 % | 15.0 % | 13.9 % | 1.00 |
| BDH Industries Ltd | 217 Cr. | 376 | 524/241 | 22.2 | 123 | 1.20 % | 17.8 % | 14.2 % | 10.0 |
| Bacil Pharma Ltd | 57.0 Cr. | 39.7 | 47.9/26.7 | 89.0 | 18.4 | 0.00 % | 0.97 % | 0.98 % | 10.0 |
| Aurobindo Pharma Ltd | 70,146 Cr. | 1,208 | 1,279/994 | 20.5 | 603 | 0.33 % | 14.2 % | 11.1 % | 1.00 |
| Auro Laboratories Ltd | 141 Cr. | 227 | 303/159 | 135 | 69.9 | 0.00 % | 3.85 % | 4.33 % | 10.0 |
| Anuh Pharma Ltd | 725 Cr. | 72.6 | 115/68.0 | 18.7 | 32.6 | 2.06 % | 17.2 % | 13.4 % | 5.00 |
| ANG Lifesciences India Ltd | 31.7 Cr. | 24.3 | 42.8/21.0 | | 50.0 | 0.00 % | 3.54 % | 13.8 % | 10.0 |
| Acutaas Chemicals Ltd | 15,642 Cr. | 1,912 | 1,968/930 | 54.5 | 173 | 0.08 % | 19.9 % | 16.0 % | 5.00 |
| Amerise Biosciences Ltd | 4.03 Cr. | 0.61 | 1.06/0.51 | 101 | 0.81 | 0.00 % | 0.19 % | 0.19 % | 1.00 |
| Ambalal Sarabhai Enterprises Ltd | 211 Cr. | 27.6 | 53.8/23.1 | 13.5 | 19.2 | 0.00 % | 9.12 % | 6.25 % | 10.0 |
| Adline Chem Lab Ltd | 7.20 Cr. | 12.3 | 19.1/7.60 | | 2.75 | 0.00 % | % | % | 10.0 |
| Achyut Healthcare Ltd | 119 Cr. | 5.07 | 6.57/2.82 | | 1.33 | 0.00 % | 2.26 % | 1.77 % | 1.00 |
| Abbott India Ltd | 58,587 Cr. | 27,565 | 37,000/25,743 | 38.8 | 1,888 | 1.72 % | 46.2 % | 35.7 % | 10.0 |
| Aarti Pharmalabs Ltd | 6,830 Cr. | 753 | 972/557 | 28.5 | 226 | 0.66 % | 17.4 % | 14.5 % | 5.00 |
| Aarey Drugs & Pharmaceuticals Ltd | 190 Cr. | 67.6 | 100/31.3 | 53.2 | 52.5 | 0.00 % | 6.38 % | 2.96 % | 10.0 |
| Zota Health Care Ltd | 4,352 Cr. | 1,288 | 1,740/752 | | 103 | 0.08 % | 17.0 % | 36.0 % | 10.0 |
| Wockhardt Ltd | 22,456 Cr. | 1,382 | 1,870/1,110 | 409 | 281 | 0.00 % | 3.75 % | 1.22 % | 5.00 |
| Wanbury Ltd | 732 Cr. | 209 | 330/154 | 17.0 | 18.1 | 0.00 % | 36.7 % | 76.5 % | 10.0 |
| Vivimed Labs Ltd | 73.2 Cr. | 8.84 | 29.4/6.65 | | 5.79 | 0.00 % | 8.10 % | % | 2.00 |
| Venus Remedies Ltd | 1,090 Cr. | 819 | 849/278 | 14.3 | 445 | 0.00 % | 11.1 % | 7.16 % | 10.0 |
| Unichem Laboratories Ltd | 2,643 Cr. | 374 | 760/361 | 18.2 | 346 | 0.00 % | 6.24 % | 5.59 % | 2.00 |
| TTK Healthcare Ltd | 1,368 Cr. | 968 | 1,402/951 | 19.6 | 768 | 1.03 % | 9.26 % | 6.89 % | 10.0 |
| Torrent Pharmaceuticals Ltd | 1,34,244 Cr. | 3,961 | 4,125/2,886 | 62.0 | 250 | 0.81 % | 27.0 % | 26.5 % | 5.00 |
| Themis Medicare Ltd | 737 Cr. | 80.2 | 255/76.0 | | 41.3 | 0.62 % | 10.4 % | 7.65 % | 1.00 |
| Syncom Formulations (India) Ltd | 1,210 Cr. | 13.0 | 23.5/11.5 | 19.2 | 4.00 | 0.00 % | 18.6 % | 15.5 % | 1.00 |
| Cohance Lifesciences Ltd | 14,632 Cr. | 381 | 1,328/368 | 42.6 | 99.0 | 0.00 % | 14.9 % | 12.7 % | 1.00 |
| Suven Life Sciences Ltd | 3,027 Cr. | 133 | 303/102 | | 12.4 | 0.00 % | 87.0 % | 87.2 % | 1.00 |
| Sun Pharmaceuticals Industries Ltd | 3,82,766 Cr. | 1,595 | 1,851/1,547 | 33.2 | 324 | 1.00 % | 20.2 % | 16.9 % | 1.00 |
| Solara Active Pharma Sciences Ltd | 2,235 Cr. | 506 | 734/441 | 349 | 347 | 0.00 % | 6.01 % | 0.05 % | 10.0 |
| SMS Pharmaceuticals Ltd | 2,964 Cr. | 317 | 360/175 | 36.5 | 81.2 | 0.13 % | 12.2 % | 11.0 % | 1.00 |
| SMS Lifesciences India Ltd | 357 Cr. | 1,197 | 1,680/956 | 20.6 | 650 | 0.13 % | 11.8 % | 10.8 % | 10.0 |
| Shilpa Medicare Ltd | 5,657 Cr. | 289 | 502/260 | 36.6 | 125 | 0.17 % | 7.82 % | 4.21 % | 1.00 |
| Sequent Scientific Ltd | 8,768 Cr. | 201 | 260/111 | 203 | 32.2 | 0.00 % | 8.47 % | 3.21 % | 2.00 |
| Sanofi India Ltd | 9,265 Cr. | 4,018 | 6,718/3,976 | 25.1 | 340 | 2.91 % | 49.2 % | 47.2 % | 10.0 |
| RPG Life Sciences Ltd | 3,321 Cr. | 2,008 | 2,725/1,772 | 31.6 | 335 | 1.00 % | 32.8 % | 25.5 % | 8.00 |
| Procter & Gamble Health Ltd | 8,815 Cr. | 5,303 | 6,739/4,904 | 28.7 | 373 | 2.36 % | 47.8 % | 36.4 % | 10.0 |
| Pharmaids Pharmaceuticals Ltd | 146 Cr. | 41.5 | 76.2/41.0 | | 14.7 | 0.00 % | 17.4 % | 16.3 % | 10.0 |
| Pfizer Ltd | 20,877 Cr. | 4,564 | 5,993/3,701 | 29.5 | 841 | 0.77 % | 21.6 % | 16.4 % | 10.0 |
| Par Drugs & Chemicals Ltd | 110 Cr. | 89.6 | 203/81.0 | 11.4 | 86.5 | 0.00 % | 18.4 % | 13.6 % | 10.0 |
| Panacea Biotec Ltd | 2,299 Cr. | 373 | 582/281 | | 135 | 0.00 % | 4.57 % | 4.92 % | 1.00 |
| Ortin Laboratories Ltd | 16.4 Cr. | 20.1 | 26.4/16.2 | | 3.47 | 0.00 % | 60.2 % | 118 % | 10.0 |
| Orchid Pharma Ltd | 3,556 Cr. | 699 | 1,512/604 | 68.0 | 251 | 0.00 % | 8.07 % | 8.21 % | 10.0 |
| Neuland Laboratories Ltd | 17,004 Cr. | 13,251 | 19,748/10,060 | 86.8 | 1,263 | 0.09 % | 18.7 % | 14.8 % | 10.0 |
| Nectar Lifescience Ltd | 261 Cr. | 13.5 | 38.9/13.0 | | 32.0 | 0.00 % | 5.36 % | 11.2 % | 1.00 |
| Natco Pharma Ltd | 14,966 Cr. | 836 | 1,341/660 | 9.73 | 483 | 0.72 % | 32.8 % | 28.0 % | 2.00 |
| Morepen Laboratories Ltd | 1,991 Cr. | 36.3 | 70.5/33.5 | 26.4 | 21.8 | 0.55 % | 15.1 % | 11.8 % | 2.00 |
| Marksans Pharma Ltd | 7,428 Cr. | 164 | 276/156 | 21.1 | 59.3 | 0.49 % | 20.0 % | 16.8 % | 1.00 |
| Mangalam Drugs and Organics Ltd | 57.2 Cr. | 36.2 | 123/22.7 | | 80.5 | 0.00 % | 8.03 % | 4.71 % | 10.0 |
| Lyka Labs Ltd | 259 Cr. | 71.7 | 157/70.2 | | 28.3 | 0.00 % | 9.91 % | 9.31 % | 10.0 |
| Lupin Ltd | 98,390 Cr. | 2,153 | 2,228/1,774 | 22.8 | 430 | 0.56 % | 21.3 % | 20.6 % | 2.00 |
| Lincoln Pharmaceuticals Ltd | 911 Cr. | 456 | 809/440 | 11.4 | 357 | 0.39 % | 17.3 % | 12.8 % | 10.0 |
| Laurus Labs Ltd | 52,187 Cr. | 965 | 1,141/512 | 65.2 | 91.1 | 0.12 % | 9.47 % | 7.75 % | 2.00 |
| Kwality Pharmaceuticals Ltd | 1,105 Cr. | 1,065 | 1,235/596 | 22.5 | 281 | 0.00 % | 18.2 % | 16.2 % | 10.0 |
| Krebs Biochemicals & Industries Ltd | 129 Cr. | 58.8 | 114/53.0 | | 73.2 | 0.00 % | 30.1 % | % | 10.0 |
| Kopran Ltd | 620 Cr. | 128 | 215/123 | 37.4 | 104 | 2.34 % | 9.75 % | 7.64 % | 10.0 |
| Kilitch Drugs (India) Ltd | 549 Cr. | 314 | 500/265 | 19.9 | 152 | 0.00 % | 15.7 % | 12.6 % | 10.0 |
| Jubilant Pharmova Ltd | 15,672 Cr. | 982 | 1,250/802 | 31.5 | 414 | 0.51 % | 9.54 % | 9.55 % | 1.00 |
| J B Chemicals & Pharmaceuticals Ltd | 30,014 Cr. | 1,870 | 1,939/1,303 | 39.8 | 243 | 0.83 % | 25.8 % | 20.1 % | 1.00 |
| Jagsonpal Pharmaceuticals Ltd | 1,129 Cr. | 169 | 302/155 | 26.5 | 37.9 | 1.48 % | 23.0 % | 18.6 % | 2.00 |
| Ipca Laboratories Ltd | 37,254 Cr. | 1,471 | 1,595/1,168 | 37.6 | 293 | 0.27 % | 14.7 % | 12.8 % | 1.00 |
| IOL Chemicals & Pharmaceuticals Ltd | 2,174 Cr. | 74.0 | 127/57.5 | 18.7 | 59.7 | 1.08 % | 8.86 % | 6.13 % | 2.00 |
| Ind-Swift Ltd | 85.4 Cr. | 15.8 | 20.0/12.0 | 10.9 | 74.2 | 0.00 % | 11.9 % | % | 2.00 |
| Ind-Swift Laboratories Ltd | 925 Cr. | 113 | 124/67.2 | 31.2 | 160 | 0.00 % | 0.78 % | 0.18 % | 10.0 |
| Indoco Remedies Ltd | 2,007 Cr. | 218 | 350/190 | | 106 | 0.09 % | 0.49 % | 7.02 % | 2.00 |
| Hikal Ltd | 2,371 Cr. | 193 | 457/189 | 235 | 96.9 | 0.73 % | 9.85 % | 7.38 % | 2.00 |
| Hester Biosciences Ltd | 1,265 Cr. | 1,484 | 2,350/1,243 | 30.9 | 397 | 0.47 % | 9.71 % | 9.18 % | 10.0 |
| Gufic BioSciences Ltd | 3,077 Cr. | 307 | 460/285 | 56.7 | 62.7 | 0.03 % | 13.2 % | 12.3 % | 1.00 |
| Granules India Ltd | 13,850 Cr. | 571 | 627/412 | 25.5 | 164 | 0.26 % | 15.1 % | 13.9 % | 1.00 |
| Glenmark Pharmaceuticals Ltd | 56,856 Cr. | 2,016 | 2,286/1,275 | 22.6 | 340 | 0.12 % | 19.4 % | 15.8 % | 1.00 |
| Glaxosmithkline Pharmaceuticals Ltd | 40,736 Cr. | 2,402 | 3,516/1,921 | 42.7 | 101 | 1.75 % | 63.2 % | 46.9 % | 10.0 |
| Gland Pharma Ltd | 30,436 Cr. | 1,847 | 2,131/1,200 | 25.6 | 610 | 0.97 % | 15.8 % | 11.6 % | 1.00 |
| FDC Ltd | 6,152 Cr. | 378 | 528/359 | 27.3 | 149 | 1.32 % | 15.9 % | 11.8 % | 1.00 |
| ERIS Lifesciences Ltd | 19,047 Cr. | 1,376 | 1,910/1,097 | 45.8 | 227 | 0.53 % | 12.2 % | 12.9 % | 1.00 |
| Dr Reddys Laboratories Ltd | 1,01,704 Cr. | 1,218 | 1,380/1,020 | 18.3 | 432 | 0.66 % | 22.7 % | 18.0 % | 1.00 |
| Dishman Carbogen Amcis Ltd | 3,420 Cr. | 218 | 322/178 | 22.9 | 406 | 0.00 % | 2.42 % | 0.32 % | 2.00 |
| Cipla Ltd | 1,06,995 Cr. | 1,324 | 1,673/1,282 | 22.5 | 408 | 0.98 % | 22.7 % | 17.8 % | 2.00 |
| Caplin Point Laboratories Ltd | 13,497 Cr. | 1,774 | 2,397/1,551 | 22.9 | 416 | 0.34 % | 25.8 % | 22.7 % | 2.00 |
| Brooks Laboratories Ltd | 181 Cr. | 61.6 | 166/61.3 | 12.9 | 39.3 | 0.00 % | 9.93 % | 12.2 % | 10.0 |
| Bliss GVS Pharma Ltd | 1,868 Cr. | 177 | 196/105 | 17.0 | 107 | 0.28 % | 11.7 % | 8.36 % | 1.00 |
| Biofil Chemicals & Pharmaceuticals Ltd | 47.5 Cr. | 29.3 | 58.0/28.5 | 16.7 | 13.1 | 0.00 % | 4.12 % | 3.03 % | 10.0 |
| Biocon Ltd | 59,422 Cr. | 367 | 425/291 | 125 | 200 | 0.14 % | 6.25 % | 4.76 % | 5.00 |
| Beta Drugs Ltd | 1,479 Cr. | 1,465 | 2,000/1,430 | 32.7 | 219 | 0.00 % | 27.0 % | 25.9 % | 10.0 |
| Bal Pharma Ltd | 107 Cr. | 66.8 | 129/65.0 | 15.7 | 49.2 | 1.80 % | 10.1 % | 9.66 % | 10.0 |
| Bafna Pharmaceuticals Ltd | 264 Cr. | 112 | 205/67.8 | 25.0 | 38.6 | 0.00 % | 8.34 % | 7.69 % | 10.0 |
| Astrazeneca Pharma India Ltd | 21,389 Cr. | 8,550 | 10,691/6,502 | 92.5 | 320 | 0.37 % | 33.4 % | 23.6 % | 2.00 |
| Amrutanjan Health Care Ltd | 1,693 Cr. | 584 | 791/544 | 29.9 | 118 | 0.79 % | 22.4 % | 16.5 % | 1.00 |
| Alpa Laboratories Ltd | 142 Cr. | 68.1 | 125/61.0 | 7.57 | 92.0 | 0.00 % | 15.0 % | 11.5 % | 10.0 |
| Alkem Laboratories Ltd | 67,929 Cr. | 5,678 | 5,934/4,492 | 28.9 | 1,116 | 0.79 % | 20.4 % | 19.4 % | 2.00 |
| Alembic Pharmaceuticals Ltd | 15,379 Cr. | 783 | 1,108/725 | 24.2 | 271 | 1.40 % | 13.0 % | 11.4 % | 2.00 |
| Albert David Ltd | 394 Cr. | 687 | 1,219/663 | | 690 | 0.73 % | 6.45 % | 4.39 % | 10.0 |
| Ajanta Pharma Ltd | 34,758 Cr. | 2,782 | 3,080/2,022 | 34.3 | 345 | 1.01 % | 32.4 % | 24.9 % | 2.00 |
| Advanced Enzyme Technologies Ltd | 3,319 Cr. | 297 | 367/258 | 22.5 | 133 | 1.75 % | 13.1 % | 9.54 % | 2.00 |
| Aarti Drugs Limited | 3,480 Cr. | 381 | 575/312 | 18.3 | 147 | 0.26 % | 13.5 % | 13.0 % | 10.0 |
| Industry Average | 19,586.73 Cr | 1,092.47 | | 46.76 | 202.32 | 0.38% | 16.29% | 15.20% | 6.10 |